Was thrilled to moderate this research panel Center for Pharmaceutical Policy and Prescribing #Pharmacoequity2024 conference today! Ink Factory vertically enhanced the presentations.

Very excited for these award winners - what they will bring to the conference and how this will impact their careers and contribution to #pharmacoequity ! Thanks to our sponsors and the international interest in this opportunity!

So proud of my RA Mx. Taylor Boyer and my collaborator Dr. John Blosnich for receiving this award from VA!

Our work was highlighted by the funder of our R01! Inmaculada (Inma) Hernández Katherine Callaway Kim Walid Gellad Mina T.

CP3's SUDAmonas & Katherine Callaway Kim are doing major work to understand the causes of drug shortages and how to prevent them from happening in the future.

health.pitt.edu/news/pitt-rese…

🆕 JAMA Network Open: our team of #drugshortage experts examined shortages before and during #COVID19 to learn more about vulnerabilities & how to protect future supplies.

jamanetwork.com/journals/jaman…

With Mina T. Inmaculada (Inma) Hernández & CP3's Katherine Callaway Kim Walid Gellad SUDAmonas

Pitt Public Health Dean's Day starts tomorrow! Be sure to check out posters from 2 of our incredible doctoral students, Katherine Callaway Kim & Yilei Liu! Both are working with our SUDAmonas.

New opportunity for students to receive a scholarship to attend our #Pharmacoequity2024 conference! Please disseminate to your network.

🚨Students!🚨
If you're interested in #Pharmacoequity and want to attend our #Pharmacoequity 2024 Conference in Pittsburgh to learn from & network with national experts, we have a SCHOLARSHIP OPPORTUNITY coming soon! Watch this space!

cp3.pitt.edu/events/pharmac…

⏰ We’re just about 6 weeks away!

Register today for #Pharmacoequity2024 !

📆: Friday, May 3rd
📍: In-Person @ Pittsburgh, PA
🔗: calendar.pitt.edu/event/3rd_annu…

Looking forward to our 3rd Annual Conference with some amazing speakers,
including Fumiko Ladd Chino, MD our keynote talk.

1/2

Predictors for post-extraction complications among complex patients who DID NOT receive abx prior to extractions were similar to prior work in cohorts who received abx. More evidence that abx do not mitigate complications! Charlesnika T Evans Jessina McGregor

❓Did the #valsartan recall affect ❤️failure patients' care?
✅Analysis shows no effect on short-term outcomes.

More: onlinelibrary.wiley.com/doi/10.1002/pd…

From CP3's Katherine Callaway Kim Walid Gellad SUDAmonas

International Society for Pharmacoepidemiology Mina T. Inmaculada (Inma) Hernández

Why do we tolerate ‘unknown’ for manufacturers of essential medicines and their components? FDA legally can’t disclose - but Congress CAN change the labeling laws for more transparency. Great story Riley Ray Griffin Anna Edney